(Q39924722)

15 September 2017

The effects of systemic and intratumoral interleukin-12 treatment in C6 rat glioma model (English)

1 reference

15 September 2017

Necmettin Tanriover

1

1 reference

15 September 2017

Mustafa O Ulu

2

1 reference

15 September 2017

Galip Z Sanus

3

1 reference

15 September 2017

Ayhan Bilir

4

1 reference

15 September 2017

Resit Canbeyli

5

1 reference

15 September 2017

Buge Oz

6

1 reference

15 September 2017

Ziya Akar

7

1 reference

15 September 2017

Cengiz Kuday

8

1 reference

15 September 2017

1 June 2008

1 reference

15 September 2017

Neurological Research

1 reference

15 September 2017

30

1 reference

15 September 2017

511-517

1 reference

15 September 2017

5

1 reference

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

15 September 2017

1 reference

https://api.crossref.org/works/10.1179%2F174313208X289516

21 January 2018

Brain tumors. Part 1.

1 reference

https://api.crossref.org/works/10.1179%2F174313208X289516

Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X289516

Prolonged survival of mice with glioma injected intracerebrally with double cytokine-secreting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X289516

Cytokines and immunoregulatory molecules in malignant glial neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X289516

Improved long term survival after intracavitary interleukin-2 and lymphokine-activated killer cells for adults with recurrent malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X289516

Human glioma-derived interleukin-10 inhibits antitumor immune responses in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X289516

In vivo transfer of the human interleukin-2 gene: negative tumoricidal results in experimental brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X289516

Antitumor activity of interleukin-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X289516

Antiangiogenic gene therapy of cancer: recent developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X289516

Systemic interleukin 12 displays anti-tumour activity in the mouse central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X289516

Human glioma immunobiology in vitro: implications for immunogene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X289516

Effective induction of antiglioma cytotoxic T cells by coadministration of interferon-beta gene vector and dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X289516

Induction of an antitumor immunological response by an intratumoral injection of dendritic cells pulsed with genetically engineered Semliki Forest virus to produce interleukin-18 combined with the systemic administration of interleukin-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X289516

Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X289516

New molecular strategies to cure brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X289516

Inhibition of lymphocyte function by glioblastoma-derived transforming growth factor beta 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X289516

Apoptotic elimination of peripheral T lymphocytes in patients with primary intracranial tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X289516

Modulation of T-cell function by gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X289516

Antitumor and antimetastatic activity of interleukin 12 against murine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X289516

Interleukin-12-based immunotherapy against rat 9L glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X289516

Paracrine delivery of IL-12 against intracranial 9L gliosarcoma in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X289516

Effects of combined granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2, and interleukin-12 based immunotherapy against intracranial glioma in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X289516

Lymphocytic infiltration in gliomas: evidence of possible host resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X289516

Relationship of lymphocyte invasion and survival of brain tumor patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X289516

21 January 2018

Identifiers

DOI

10.1179/174313208X289516

1 reference

15 September 2017

1 reference